ArticleFolia microbiologica2026
When probiotics turn deadly: a case of Lacticaseibacillus rhamnosus sepsis in a burn patient.
Article in Folia microbiologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
We report the first comprehensive documented case of sepsis caused by Lacticaseibacillus rhamnosus infection, likely resulting from high-dose probiotic supplementation. This sepsis occured in a 36-year-old woman with deep partial- and full-thickness burns covering 25% of total body surface area. The use of probiotics in patients with organ dysfunction and in immunocompromised individuals is on the rise. The immune system and intestinal barriers are often compromised in patients with burns, which may facilitate the translocation of probiotic bacteria into bloodstream and lead to bacteremia; however, isolation of lactobacilli in blood cultures is often disregarded and considered an artefact caused by contamination. This case highlights that probiotic-associated L. rhamnosus sepsis, although rare, can occur in these patients and excessive probiotic use should therefore be avoided in these individuals.
Indexed as
Identifiers
41820736What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.